Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:BXRX

Baudax Bio (BXRX) Stock Price, News & Analysis

About Baudax Bio Stock (NASDAQ:BXRX)

Advanced Chart

Key Stats

Today's Range
$0.02
$0.02
50-Day Range
$0.02
$0.03
52-Week Range
$0.01
$3.47
Volume
310,872 shs
Average Volume
281,029 shs
Market Capitalization
$1.14 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive BXRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Baudax Bio and its competitors with MarketBeat's FREE daily newsletter.

BXRX Stock News Headlines

Baudax Bio Announces Corporate Update
Trump’s betrayal exposed
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.
Why Is Baudax Bio (BXRX) Stock Up 75% Today?
See More Headlines

BXRX Stock Analysis - Frequently Asked Questions

Baudax Bio, Inc. (NASDAQ:BXRX) issued its earnings results on Wednesday, August, 16th. The company reported ($1.49) earnings per share for the quarter, topping the consensus estimate of ($2.04) by $0.55.

Baudax Bio shares reverse split on Wednesday, November 30th 2022.The 1-40 reverse split was announced on Wednesday, November 30th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, November 30th 2022. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that Baudax Bio investors own include Vanguard Dividend Appreciation ETF (VIG), Vanguard Total Stock Market ETF (VTI), iShares Russell 1000 Growth ETF (IWF), Schlumberger (SLB), ARK Innovation ETF (ARKK), Meta Platforms (META) and NVIDIA (NVDA).

Company Calendar

Last Earnings
8/16/2023
Today
7/29/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:BXRX
CIK
1780097
Employees
9
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($9.23)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$58.79 million
Net Margins
N/A
Pretax Margin
-18,950.64%
Return on Equity
N/A
Return on Assets
-175.11%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.07
Quick Ratio
0.07

Sales & Book Value

Annual Sales
$1.27 million
Price / Sales
0.90
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($14.93) per share
Price / Book
0.00

Miscellaneous

Outstanding Shares
52,460,000
Free Float
52,408,000
Market Cap
$1.14 million
Optionable
Not Optionable
Beta
1.57
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for August 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NASDAQ:BXRX) was last updated on 7/29/2025 by MarketBeat.com Staff
From Our Partners